VCD-D FOR TRANSPLANT INELIGIBLE MYELOMA (PHASE II)
AMaRC 03-16
KAPPAMAB FOR RELAPSED REFRACTORY MULTIPLE MYELOMA (PHASE IIB)
AMaRC 16-01
ITD FOR RELAPSED REFRACTORY MULTIPLE MYELOMA (PHASE II)
AMaRC 16-02
Publications
Celebrating the research activities and achievements of our sponsored Investigator-Initiated Trials